Direktorat Registrasi ObatValid

KADCYLA

Claim this product
BPOM Number
DKI1857507444A1
Approved
21 November 2024
Expiry
28 December 2023
Form
SERBUK INJEKSI; 100 mg

About This Registration

KADCYLA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1857507444A1. Its current registration status is Valid, with the licence valid until 28 December 2023. The product is registered to BOEHRINGER INGELHEIM INDONESIA - INDONESIA. BPOM first approved this registration in December 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 100 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

TRASTUZUMAB EMTANSINE

Market Intelligence

Owner Portfolio
BOEHRINGER INGELHEIM INDONESIA - INDONESIA holds 80 BPOM registrations
Manufacturer Scale
BOEHRINGER INGELHEIM INDONESIA - INDONESIA produces 80 registered products
Registration Age
Registered for 5 years, 9 months
Expiry Status
Expired 1002 days ago

FDA Cross-Reference

via openFDA
Generic Name
ADO-TRASTUZUMAB EMTANSINE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1